Innovus Pharma Announces U.S. Food and Drug Administration Clearance of its GlucoGorx™ Glucose Monitoring Device Test Kit

April 12, 2018
SAN DIEGO--(BUSINESS WIRE)--Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women's health and respiratory diseases, today announced that the U.S. Food and Drug Administration (“FDA”) has cleared the Company’s GlucoGorx™ Glucose Monitoring Test Kit that includes a glucose meter,
Advertisement

Recent related news

PRINCETON, N.J.--(BUSINESS WIRE)--$BMY #BristolMyers--U.S. Food and Drug Administration Accepts Supplemental Biologics License Application for Opdivo (nivolumab)
13 hours ago • Business Wire

NEW YORK CITY (dpa-AFX) - Today's Daily Dose brings you news about FDA clearance of Innovus' GlucoGorx Glucose Monitoring Test Kit; Nymox securing equity...
6 days ago • FinanzNachrichten.de

RUTHERFORD, N.J., April 16, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular...
3 days ago • GlobeNewswire

You might like